These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 37769321)

  • 1. The intricate role of CCL5/CCR5 axis in Alzheimer disease.
    Ma W; Liu A; Wu X; Gao L; Chen J; Wu H; Liu M; Fan Y; Peng L; Yang J; Kong J; Li B; Ji Z; Dong Y; Luo S; Song J; Bao F
    J Neuropathol Exp Neurol; 2023 Oct; 82(11):894-900. PubMed ID: 37769321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and biological functions of the CCL5-CCR5 axis in oral lichen planus.
    Shan J; Li S; Wang C; Liu L; Wang X; Zhu D; Fan Y; Xu J
    Exp Dermatol; 2019 Jul; 28(7):816-821. PubMed ID: 31006151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the CCL5/CCR5 Axis against the Progression of Gastric Cancer.
    Aldinucci D; Casagrande N
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical study of the beta-chemokine receptors CCR3 and CCR5 and their ligands in normal and Alzheimer's disease brains.
    Xia MQ; Qin SX; Wu LJ; Mackay CR; Hyman BT
    Am J Pathol; 1998 Jul; 153(1):31-7. PubMed ID: 9665462
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Battaglin F; Baca Y; Millstein J; Yang Y; Xiu J; Arai H; Wang J; Ou FS; Innocenti F; Mumenthaler SM; Jayachandran P; Kawanishi N; Lenz A; Soni S; Algaze S; Zhang W; Khoukaz T; Roussos Torres E; Seeber A; Abraham JP; Lou E; Philip PA; Weinberg BA; Shields AF; Goldberg RM; Marshall JL; Venook AP; Korn WM; Lenz HJ
    J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38212126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripheral chemokine receptors, their ligands, cytokines and Alzheimer's disease.
    Reale M; Iarlori C; Feliciani C; Gambi D
    J Alzheimers Dis; 2008 Jun; 14(2):147-59. PubMed ID: 18560127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arrestin Recruitment to C-C Chemokine Receptor 5: Potent C-C Chemokine Ligand 5 Analogs Reveal Differences in Dependence on Receptor Phosphorylation and Isoform-Specific Recruitment Bias.
    Martins E; Brodier H; Rossitto-Borlat I; Ilgaz I; Villard M; Hartley O
    Mol Pharmacol; 2020 Nov; 98(5):599-611. PubMed ID: 32943494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infiltrating CD8+ T cells in oral lichen planus predominantly express CCR5 and CXCR3 and carry respective chemokine ligands RANTES/CCL5 and IP-10/CXCL10 in their cytolytic granules: a potential self-recruiting mechanism.
    Iijima W; Ohtani H; Nakayama T; Sugawara Y; Sato E; Nagura H; Yoshie O; Sasano T
    Am J Pathol; 2003 Jul; 163(1):261-8. PubMed ID: 12819030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential to target CCL5/CCR5 in breast cancer.
    Velasco-Velázquez M; Xolalpa W; Pestell RG
    Expert Opin Ther Targets; 2014 Nov; 18(11):1265-75. PubMed ID: 25256399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACKR2 contributes to pulmonary dysfunction by shaping CCL5:CCR5-dependent recruitment of lymphocytes during influenza A infection in mice.
    Tavares LP; Garcia CC; Gonçalves APF; Kraemer LR; Melo EM; Oliveira FMS; Freitas CS; Lopes GAO; Reis DC; Cassali GD; Machado AM; Mantovani A; Locati M; Teixeira MM; Russo RC
    Am J Physiol Lung Cell Mol Physiol; 2020 Apr; 318(4):L655-L670. PubMed ID: 31995405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CCL5-armed oncolytic virus augments CCR5-engineered NK cell infiltration and antitumor efficiency.
    Li F; Sheng Y; Hou W; Sampath P; Byrd D; Thorne S; Zhang Y
    J Immunother Cancer; 2020 Feb; 8(1):. PubMed ID: 32098828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemokine C-C motif receptor 5 and C-C motif ligand 5 promote cancer cell migration under hypoxia.
    Lin S; Wan S; Sun L; Hu J; Fang D; Zhao R; Yuan S; Zhang L
    Cancer Sci; 2012 May; 103(5):904-12. PubMed ID: 22380870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CCL5/CCR5 axis contributes to the perineural invasion of human salivary adenoid cystic carcinoma.
    Shen Z; Li T; Chen D; Jia S; Yang X; Liang L; Chai J; Cheng X; Yang X; Sun M
    Oncol Rep; 2014 Feb; 31(2):800-6. PubMed ID: 24337063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CCL5/CCR5 Axis Promotes Vascular Smooth Muscle Cell Proliferation and Atherogenic Phenotype Switching.
    Lin CS; Hsieh PS; Hwang LL; Lee YH; Tsai SH; Tu YC; Hung YW; Liu CC; Chuang YP; Liao MT; Chien S; Tsai MC
    Cell Physiol Biochem; 2018; 47(2):707-720. PubMed ID: 29794461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment.
    Wang SW; Liu SC; Sun HL; Huang TY; Chan CH; Yang CY; Yeh HI; Huang YL; Chou WY; Lin YM; Tang CH
    Carcinogenesis; 2015 Jan; 36(1):104-14. PubMed ID: 25330803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of periostin in inflammatory bowel disease development and synergistic effects mediated by the CCL5-CCR5 axis.
    Mukanova S; Borissenko A; Kim A; Bolatbek A; Abdrakhmanova A; Vangelista L; Sonnenberg-Riethmacher E; Riethmacher D
    Front Immunol; 2022; 13():956691. PubMed ID: 36341422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokine Ligand 5 (CCL5) Derived from Endothelial Colony-Forming Cells (ECFCs) Mediates Recruitment of Smooth Muscle Progenitor Cells (SPCs) toward Critical Vascular Locations in Moyamoya Disease.
    Phi JH; Suzuki N; Moon YJ; Park AK; Wang KC; Lee JY; Choi SA; Chong S; Shirane R; Kim SK
    PLoS One; 2017; 12(1):e0169714. PubMed ID: 28072843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the CCL5 and Its Receptor, CCR5, in the Genesis of Aldosterone-Induced Hypertension, Vascular Dysfunction, and End-Organ Damage.
    Costa RM; Cerqueira DM; Bruder-Nascimento A; Alves JV; Awata WMC; Singh S; Kufner A; Prado DS; Johny E; Cifuentes-Pagano E; Hawse WF; Dutta P; Pagano PJ; Ho J; Bruder-Nascimento T
    Hypertension; 2024 Apr; 81(4):776-786. PubMed ID: 38240165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allovalency observed by transferred NOE: interactions of sulfated tyrosine residues in the N-terminal segment of CCR5 with the CCL5 chemokine.
    Kessler N; Akabayov SR; Moseri A; Cohen LS; Sakhapov D; Bolton D; Fridman B; Kay LE; Naider F; Anglister J
    FEBS J; 2021 Mar; 288(5):1648-1663. PubMed ID: 32814359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chemokine CCL5 regulates the in vivo cell surface expression of its receptor, CCR5.
    Lin YL; Mettling C; Portalès P; Rouzier R; Clot J; Reynes J; Corbeau P
    AIDS; 2008 Jan; 22(3):430-2. PubMed ID: 18195571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.